<code id='09161B4D7E'></code><style id='09161B4D7E'></style>
    • <acronym id='09161B4D7E'></acronym>
      <center id='09161B4D7E'><center id='09161B4D7E'><tfoot id='09161B4D7E'></tfoot></center><abbr id='09161B4D7E'><dir id='09161B4D7E'><tfoot id='09161B4D7E'></tfoot><noframes id='09161B4D7E'>

    • <optgroup id='09161B4D7E'><strike id='09161B4D7E'><sup id='09161B4D7E'></sup></strike><code id='09161B4D7E'></code></optgroup>
        1. <b id='09161B4D7E'><label id='09161B4D7E'><select id='09161B4D7E'><dt id='09161B4D7E'><span id='09161B4D7E'></span></dt></select></label></b><u id='09161B4D7E'></u>
          <i id='09161B4D7E'><strike id='09161B4D7E'><tt id='09161B4D7E'><pre id='09161B4D7E'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:47
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more

          Whathappenswhenanapproveddrugdoesn’twork?Whydon’tpatientswantgenetherapy?AndisMASHstillabigdeal?Weco

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Readout LOUD podcast: ALS dilemma, first MASH drug, and more

          Whathappenswhenanapproveddrugdoesn’twork?Whydon’tpatientswantgenetherapy?AndisMASHstillabigdeal?Weco